Strategies for improving drug delivery: nanocarriers and microenvironmental priming
文献类型：期刊论文
| 作者 | Khalid, Ayesha1; Persano, Stefano2; Shen, Haifa2,3; Zhao, Yuliang4,5; Blanco, Elvin2; Ferrari, Mauro2,6; Wolfram, Joy2,4 |
| 刊名 | Expert opinion on drug delivery
 |
| 出版日期 | 2017 |
| 卷号 | 14期号:7页码:865-877 |
| 关键词 | Biodistribution Biological barrier Nanodelivery system Priming agents Transport ocophysics |
| ISSN号 | 1742-5247 |
| DOI | 10.1080/17425247.2017.1243527 |
| 通讯作者 | Wolfram, joy(jvwolfram@houstonmethodist.org) |
| 英文摘要 | Introduction: the ultimate goal in the field of drug delivery is to exclusively direct therapeutic agents to pathological tissues in order to increase therapeutic efficacy and eliminate side effects. this goal is challenging due to multiple transport obstacles in the body. strategies that improve drug transport exploit differences in the characteristics of normal and pathological tissues. within the field of oncology, these concepts have laid the groundwork for a new discipline termed transport oncophysics. areas covered: efforts to improve drug biodistribution have mainly focused on nanocarriers that enable preferential accumulation of drugs in diseased tissues. a less common approach to enhance drug transport involves priming strategies that modulate the biological environment in ways that favor localized drug delivery. this review discusses a variety of priming and nanoparticle design strategies that have been used for drug delivery. expert opinion: combinations of priming agents and nanocarriers are likely to yield optimal drug distribution profiles. although priming strategies have yet to be widely implemented, they represent promising solutions for overcoming biological transport barriers. in fact, such strategies are not restricted to priming the tumor microenvironment but can also be directed toward healthy tissue in order to reduce nanoparticle uptake. |
| WOS关键词 | ALBUMIN-BOUND PACLITAXEL ; ADVANCED PANCREATIC-CANCER ; PHASE-II TRIAL ; PROTEIN CORONA ; IN-VIVO ; SOLID TUMORS ; MACROMOLECULAR THERAPEUTICS ; TUMORITROPIC ACCUMULATION ; TARGETED NANOPARTICLES ; LIPID NANOPARTICLES |
| WOS研究方向 | Pharmacology & Pharmacy |
| WOS类目 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000404938000004 |
| 出版者 | TAYLOR & FRANCIS LTD |
| URI标识 | http://www.irgrid.ac.cn/handle/1471x/2177284 |
| 专题 | 高能物理研究所 |
| 通讯作者 | Wolfram, Joy |
| 作者单位 | 1.Qatar Fdn, Program Med, Weill Cornell Med Qatar, Doha, Qatar 2.Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA 3.Weill Cornell Med, Dept Cell & Dev Biol, New York, NY USA 4.Univ Chinese Acad Sci, Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China 5.Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China 6.Weill Cornell Med, Dept Med, New York, NY USA |
| 推荐引用方式 GB/T 7714 | Khalid, Ayesha,Persano, Stefano,Shen, Haifa,et al. Strategies for improving drug delivery: nanocarriers and microenvironmental priming[J]. Expert opinion on drug delivery,2017,14(7):865-877. |
| APA | Khalid, Ayesha.,Persano, Stefano.,Shen, Haifa.,Zhao, Yuliang.,Blanco, Elvin.,...&Wolfram, Joy.(2017).Strategies for improving drug delivery: nanocarriers and microenvironmental priming.Expert opinion on drug delivery,14(7),865-877. |
| MLA | Khalid, Ayesha,et al."Strategies for improving drug delivery: nanocarriers and microenvironmental priming".Expert opinion on drug delivery 14.7(2017):865-877. |
入库方式： iSwitch采集
来源：高能物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。